Molecules/MAFTIVIMAB

MAFTIVIMAB

Molecular Identity

AntibodyApprovedFirst approved 2020

Mechanism of action: Envelope glycoprotein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

MAFTIVIMABMAFTIVIMAB COMPONENT OF INMAZEB -EBGNMAFTIVIMAB COMPONENT OF REGN-EB3MAFTIVIMAB-EBGNREGN-3479REGN3479

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to MAFTIVIMAB

Loading drug network...